Par Pharmaceutical (PRX) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Financial Fact:
Operating (loss) income: 45.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating (loss) income: 45.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Par Pharmaceutical (NYSE: PRX) reported Q1 EPS of $0.80, $0.08 better than the analyst estimate of $0.72. Revenue for the quarter came in at $271.5 million versus the consensus estimate of $230.84 million.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
